|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- Social Care Providers (registered with CAS)
- NHS Trusts (England) - Medical Director
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- Out of hours contacts
- Community Pharmacy
- Primary Care Networks
- GP Practices 1
|
Action category: |
|
Important information for immediate action
|
Title: |
|
Update on COVID-19 Variant B.1.1.529
|
Broadcast content: |
|
Data is still emerging on Variant B.1.1.529 but it is currently a significant concern. It is now
designated as a Variant of Concern by the World Health Organisation and the UK. The New
and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) met on 26/11/2021, this alert provides a summary of what the group discussed alongside the latest advice for the public and healthcare workers.
We also attach a note
on Omicron enhanced surveillance for testing laboratories, for your
information.
|
Additional information: |
|
NHS England and NHS Improvement Regional Offices: please cascade to community pharmacy, dental and optometry contractors.
|